GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Austar Lifesciences 6118.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

0.53

-1.87%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Austar Lifesciences

Its shares trade on HKEX under the ticker 6118.HK. It has been listed since 7 November 2014. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.53bn and net income of CN¥33.8m. At that date it held total assets of CN¥2.13bn and shareholders' equity of CN¥822.9m.

Austar Lifesciences Ltd. operates as an investment holding company. The company is headquartered in Beijing, Beijing. The company went IPO on 2014-11-07. The firm operates its business through six segments: liquid and bioprocess system segment, clean room and automation control and monitoring system segment, powder and solid system segment, good manufacturing practice (GMP) compliance service segment, life science consumables segment and distribution and agency of pharmaceutical equipment segment.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Life Sciences Tools & Services
Listed since
7 Nov 2014
Employees
1,325

Leadership

Pay as last reported

  • Mr. Kwok Keung HoChief Executive Officer, Executive Chairman of the Board, since 2014CN¥865,000
  • Ms. Xiangdi TangVice President of Corporate Development
  • Ms. Wei WangVice President
  • Mr. Ce BianExecutive Director, since 2025
  • Mr. Kin Hung HoExecutive Director, since 2014CN¥2.1m
  • Ms. Ning ZhouExecutive Director, since 2014CN¥976,000
  • Ms. Yuk Kiu MakCompany Secretary
  • Ms. Lingling JiNon-Executive DirectorCN¥591,000
  • Mr. Lap Kei CheungNon-Executive Independent DirectorCN¥149,000
  • Ms. Hoi Shan ChiuNon-Executive Independent DirectorCN¥149,000
  • Mr. Oi Kin LeungNon-Executive Independent DirectorCN¥149,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Austar Lifesciences Ltd has several strengths that contribute to its success in the market. These include:

Weaknesses

  • Despite its strengths, Austar Lifesciences Ltd also faces certain weaknesses that can hinder its performance. These weaknesses include:

Opportunities

  • Austar Lifesciences Ltd can capitalize on various opportunities to enhance its market position and growth prospects. These opportunities include:

Threats

  • Austar Lifesciences Ltd faces several threats that can impact its performance and competitive position. These threats include:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.